PRPH Cash Flow Breakdown | ProPhase Labs, Inc.

ProPhase Labs, Inc. Cash Flow Breakdown

Cash flow breakdown shows where ProPhase Labs, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $8.34M went out.
Fiscal year ended 2025-12-31: from investing, $920.00K came in.
Fiscal year ended 2025-12-31: from financing, $6.84M came in.
Fiscal year ended 2025-12-31: change in cash, $588.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Buybacks	Dividends	Debt paid back	New debt	Staff share tax	New shares sold	Not split out	Change in cash
2025-12-31	-$8.34M	$920.00K						$3.56M	$3.28M*	-$588.00K
2024-12-31	-$17.54M	$2.42M	$0.00				$0.00	$0.00	$14.19M*	-$931.00K
2023-12-31	-$11.89M	-$1.37M	-$588.00K	$0.00			-$5.38M	$0.00	$11.72M*	-$7.50M
2022-12-31	$28.55M	-$2.08M	-$2.15M	-$9.35M			-$7.47M		-$7.04M*	$451.00K
2021-12-31	-$13.62M	-$19.67M	-$917.00K	-$4.55M					$40.59M*	$1.84M
2020-12-31	-$2.59M	-$1.02M				$10.00M				$6.38M
2019-12-31	-$841.00K	$5.54M		-$5.82M						-$1.12M
2018-12-31	-$2.12M	$11.86M		-$11.70M				$337.00K		-$1.62M
2017-12-31	-$2.84M	$21.77M	-$16.28M					$1.51M*		$2.73M
2016-12-31	-$472.00K	-$651.00K			-$100.00K					-$1.22M
2015-12-31	-$3.50M	-$709.00K			-$100.00K			$1.56M	$1.48M*	-$1.26M
2014-12-31	-$3.22M	-$306.00K			-$100.00K			$4.91M		$1.29M
2013-12-31	$1.14M	-$442.00K	$0.00		-$100.00K			$444.00K		$1.07M
2012-12-31	-$5.73M	-$310.00K	$0.00		$0.00			$1.07M		-$4.97M
2011-12-31	-$2.11M	-$134.00K	-$449.00K					$0.00		-$2.69M
2010-12-31	-$3.55M	-$1.15M	$0.00					$0.00		-$4.57M
2009-12-31	$445.00K	$272.00K	$0.00					$127.00K		$844.00K

Each quarter (3 month)

Quarter end	Running the business	From investing	Buybacks	Dividends	New debt	Staff share tax	New shares sold	Not split out	Change in cash
2026-06-30	-$78.00K*	$0.00*					$0.00*
2026-03-31	-$748.00K	$12.00K					$41.00K	$636.00K*	-$59.00K
2025-12-31	-$1.23M*	$0.00*					$0.00*	$915.00K*
2025-09-30	-$3.49M*	$0.00*					$0.00*	$3.72M*
2025-06-30	-$247.00K*	$67.00K*					$280.00K*
2025-03-31	-$3.38M	$853.00K					$3.28M	-$1.34M*	-$590.00K
2024-12-31	-$3.52M*	-$40.00K*	$0.00*			$0.00*	-$4.62M*	$8.36M*
2024-09-30	-$4.04M*	-$97.00K*	$0.00*			$0.00*	$0.00*	$2.86M*
2024-06-30	-$4.84M*	$124.00K*	$0.00*			$0.00*	$4.62M*	$699.00K*
2024-03-31	-$5.14M	$2.44M	$0.00			$0.00	$0.00	$2.27M*	-$434.00K
2023-12-31	-$753.00K*	-$1.26M*	$0.00*	$0.00*		$0.00*	$0.00*	$2.92M*
2023-09-30	-$4.65M*	$332.00K*	$0.00*	$0.00*		$0.00*	$0.00*	$1.20M*
2023-06-30	-$6.96M*	$1.22M*	-$47.00K*	$0.00*		$0.00*
2023-03-31	$476.00K	-$1.65M	-$541.00K	$0.00		-$5.38M		$7.60M*	$504.00K
2022-12-31	$811.00K*	-$5.00M*	-$952.00K*	-$2.00K*				-$8.54M*
2022-09-30	$2.63M*	-$670.00K*	-$50.00K*	$0.00*				-$3.07M*
2022-06-30	$4.82M*	-$488.00K*	$0.00*	-$4.71M*				-$1.48M*
2022-03-31	$20.29M	$4.08M	-$1.15M	-$4.65M				-$1.43M*	$17.15M
2021-12-31	-$4.65M*	$5.48M*		$0.00*				-$962.00K*
2021-09-30	-$5.52M*	-$3.37M*		$0.00*
2021-06-30	$4.44M*	-$14.95M*						-$4.55M*
2021-03-31	-$7.89M	-$6.83M						$40.63M*	$25.91M
2020-12-31	-$6.77M*	$2.66M*			$0.00*
2020-09-30	-$481.00K*	-$1.12M*
2020-06-30	$4.37M*	-$2.53M*
2020-03-31	$285.00K	-$22.00K							$263.00K
2019-12-31	-$428.00K*	$2.79M*		-$2.89M*
2019-09-30	-$889.00K*	$808.00K*		$0.00*
2019-06-30	-$927.00K*	-$474.00K*		$0.00*
2019-03-31	$1.40M	$2.42M		-$2.93M					$896.00K
2018-12-31	-$781.00K*	$66.00K*		$0.00*			-$1.00K*
2018-09-30	-$1.30M*	-$95.00K*		$0.00*			$0.00*		-$1.40M*
2018-06-30	$129.00K*	$11.51M*							$277.00K*
2018-03-31	-$166.00K	$381.00K							$215.00K
2017-12-31	-$1.73M*	$4.83M*	-$4.48M*				$656.00K*		-$724.00K*
2017-09-30	-$445.00K*	-$23.75M*	-$9.94M*				$752.00K*		-$33.38M*
2017-06-30	-$3.67M*	-$90.00K*						-$1.76M*	-$5.52M*
2017-03-31	$3.01M	$40.78M						-$1.43M*	$42.36M
2016-12-31	$398.00K*	-$232.00K*							$66.00K*
2016-09-30	-$682.00K*	-$92.00K*							-$774.00K*
2016-06-30	-$1.19M*	-$117.00K*							-$1.31M*
2016-03-31	$1.00M	-$210.00K							$793.00K
2015-12-31	-$1.01M*	-$40.00K*					$0.00*	$1.38M*	$328.00K*
2015-09-30	-$3.21M*	-$250.00K*					$1.04M*		-$2.42M*
2015-06-30	-$1.40M*	-$382.00K*							-$1.26M*
2015-03-31	$2.13M	-$37.00K					$0.00		$2.10M
2014-12-31	-$1.74M*	-$190.00K*					$1.00K*		-$2.03M*
2014-09-30	-$2.44M*	-$38.00K*					$83.00K*		-$2.40M*
2014-06-30	-$1.99M*	-$61.00K*					$3.88M*		$1.83M*
2014-03-31	$2.95M	-$17.00K					$947.00K		$3.88M
2013-12-31	$856.00K*	-$118.00K*					$249.00K*		$887.00K*
2013-09-30	-$3.26M*	-$74.00K*					$0.00*		-$3.31M*
2013-06-30	-$236.00K*	-$242.00K*					$0.00*		-$478.00K*
2013-03-31	$3.78M	-$8.00K					$195.00K		$3.96M
2012-12-31	-$2.34M*	$23.00K*	$0.00*				$1.07M*		-$1.24M*
2012-09-30	-$2.69M*	-$101.00K*					$0.00*		-$2.79M*
2012-06-30	-$1.47M*	-$184.00K*					$0.00*		-$1.66M*
2012-03-31	$775.00K	-$48.00K					$0.00		$727.00K
2011-12-31	$937.00K*	-$12.00K*	$0.00*				$0.00*		$925.00K*
2011-09-30	-$3.59M*	-$84.00K*					$0.00*		-$4.13M*
2011-06-30	-$649.00K*	-$194.00K*							-$843.00K*
2011-03-31	$1.20M	$156.00K							$1.35M
2010-12-31	-$466.00K*	-$7.00K*	$0.00*				$0.00*		-$473.00K*
2010-09-30	-$2.43M*	-$30.00K*					$0.00*		-$2.46M*

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
Pulmatrix, Inc. (PULM)	United States	$0.006B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26